Thus, this study aimed to investigate the clinical efficacy of various salvage therapies, including BRAFi/MEKi, cytotoxic chemotherapies, and ICIs, after PD-1 MF in patients with advanced AM. Here, PDCD1 is linked to acute myeloblastic leukemia with maturation.